[Federal Register: March 15, 2004 (Volume 69, Number 50)]
[Notices]               
[Page 12181-12182]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr04-114]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 14, 2003, and published in the Federal 
Register on December 2, 2003, (68 FR 67479), Sigma Aldrich Research 
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760, 
made application by renewal to the Drug Enforcement Administration for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
Aminorex (1585)............................  I
Alpha-ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
4-Bromo-2,5-dimethoxy-amphetamine 7391.....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
    3,4-Methylenedioxymethamphetamine        I
     (MDMA) (7405).
1-[1-(2-thienyl)cyclohexyl]piperidine (TCP)  I
 (7470).
Heroin (9200)..............................  I
Normorphine (9313).........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Diprenorphine (9058).......................  II
Ecogonine (9180)...........................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II

[[Page 12182]]


Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (9648).............  II
Carfentanil (9743).........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
laboratory reference standards and neurochemicals.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Sigma Aldrich Research 
Biochemicals, Inc. to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Sigma Aldrich Research Biochemicals, Inc. to ensure that the company's 
registration is consistent with the public interest. This investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
is granted.

    Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-5771 Filed 3-12-04; 8:45 am]

BILLING CODE 4410-09-M